REV-ERBα was identified as a T cell-specific MS susceptibility gene in a GWAS study from the MS Consortium, and REV-ERBα was among the genes differentially expressed in TH17p cells derived from human patients [32,33]. This evidence concerns the gene NR1D1 and myeloid sarcoma.